Detalhe da pesquisa
1.
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Oncologist
; 26(9): e1508-e1513, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942954
2.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
3.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952975
4.
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
Gynecol Oncol
; 159(2): 322-328, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917410
5.
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
J Clin Oncol
; 41(4): 715-723, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706735
6.
Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis.
Adv Ther
; 38(5): 2365-2378, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768419
7.
Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort.
Lung Cancer
; 155: 151-155, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831732
8.
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413166
9.
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
Clin Cancer Res
; 26(5): 1025-1033, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796520
10.
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
J Immunother Cancer
; 8(1)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554615
11.
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.
J Immunother Cancer
; 4: 70, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27879972
12.
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
J Clin Oncol
; 28(19): 3167-75, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516446